Burning Rock Biotech Ltd is a diagnostics & research business based in the US. Burning Rock Biotech Ltd shares (BNR) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $2.48 – a decrease of 15.07% over the previous week.
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $2.48 |
|---|---|
| 52-week range | $2.62 - $8.99 |
| 50-day moving average | $4.50 |
| 200-day moving average | $5.17 |
| Wall St. target price | $4.03 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-4.63 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $2.42 from 2025-05-05
| 1 week (2025-04-30) | -17.12% |
|---|---|
| 1 month (2025-04-07) | -33.42% |
| 3 months (2025-02-07) | -62.65% |
| 6 months (2024-11-07) | -32.78% |
| 1 year (2024-05-07) | 206.33% |
|---|---|
| 2 years (2023-05-05) | -91.77% |
| 3 years (2022-05-06) | 42.5 |
| 5 years (2020-05-03) | N/A |
| Revenue TTM | $515.8 million |
|---|---|
| Gross profit TTM | $362.4 million |
| Return on assets TTM | -20.93% |
| Return on equity TTM | -51.38% |
| Profit margin | -67.2% |
| Book value | $56.19 |
| Market Capitalization | $30 million |
TTM: trailing 12 months
We're not expecting Burning Rock Biotech Ltd to pay a dividend over the next 12 months.
Burning Rock Biotech Ltd's shares were split on a 1:10 basis on 14 May 2024 . So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Burning Rock Biotech Ltd shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Burning Rock Biotech Ltd shares which in turn could have impacted Burning Rock Biotech Ltd's share price.
Over the last 12 months, Burning Rock Biotech Ltd's shares have ranged in value from as little as $2.62 up to $8.99. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Burning Rock Biotech Ltd's is 0.672. This would suggest that Burning Rock Biotech Ltd's shares are less volatile than average (for this exchange).
Burning Rock Biotech Limited primarily develops and sells cancer therapy selection tests in the People's Republic of China. It operates through three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based tissue and liquid biopsy cancer therapy selection and prognosis prediction tests for various range of cancer types, including lung cancer, gastrointestinal cancer, prostate cancer, breast cancer, lymphomas, thyroid cancer, colorectal cancer, ovarian cancer, pancreatic cancer, and bladder cancer using tissue and liquid biopsy samples. Its principal products include OncoCompass IO, a corresponding test for liquid biopsy samples; OncoScreen IO, a pan-cancer test for tissue samples; and OncoCompass Target, a ctDNA liquid biopsy-based test for NSCLC. The company also provides ColonCore for assessing microsatellite loci related to MSI status and detecting mutations in genes associated with gastrointestinal cancers; and brPROPHET, a pre-operative ctDNA detection and post-operative MRD calling for relapsed patients, as well as Magnis BR-customized version of its principal products. In addition, it offers OncoMaster, an automatic NGS data analysis and report interpretation machine for in-hospital model. Burning Rock Biotech Limited has development and commercialization agreement with Myriad Genetics, Inc.
We dug through 60 years of Berkshire Hathaway annual shareholder letters to bring you 9 lessons from Warren Buffett: “The Oracle of Omaha.”
Our picks of the best brokerage accounts for index funds for beginners, teens, proprietary funds and more.
Cash sweep accounts let you earn interest on your uninvested cash. Learn how they work and how to choose the best one here.
eToro is a robust trading platform with an easy-to-use interface and no commissions on stocks and ETFs.
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
Thinking of switching from Moomoo? Here are 5 apps like Moomoo that offer valuable benefits
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .
Webull is a broker with zero-commission trading and a suite of tools to help you invest.
Here’s what you need to know about how to buy and sell stocks online in this easy to follow, step-by-step guide.